Challenge to be first in a series to crowdsource Alzheimer’s data for new disease insights .
November 11, 2013 by
November 7, 2013 by
The IP & Science Business of Thomson Reuters has announced a strategic initiative with NuMedii. The companies will leverage high-quality data, knowledge and predictive technologies to identify therapeutic candidates with the greatest probability for clinical success.
In this special guest feature, Justin Shriber of C9 advises how data science as a service opens many doors previously closed to companies wishing to capitalize on the power of predictive analytics. [Read More…]